Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 556 AL 570

mGlu(5) negative allosteric modulators: a patent review (2013 - 2016)

Emmitte KA.

Expert Opin Ther Pat. 2017 Jun;27(6):691-706. doi: 10.1080/13543776.2017.1280466. Epub 2017 Jan 19.

Endosulfine-alpha inhibits membrane-induced α-synuclein aggregation and protects against α-synuclein neurotoxicity

Ysselstein D, Dehay B, Costantino IM, McCabe GP, Frosch MP, George JM, Bezard E, Rochet JC.

Acta Neuropathol Commun. 2017 Jan 10;5(1):3. doi: 10.1186/s40478-016-0403-7.

The Search for a Peripheral Biopsy Indicator of α-Synuclein Pathology for Parkinson Disease

Lee JM, Derkinderen P, Kordower JH, Freeman R, Munoz DG, Kremer T, Zago W, Hutten SJ, Adler CH, Serrano GE, Beach TG.

J Neuropathol Exp Neurol. 2017 Jan 1;76(1):2-15. doi: 10.1093/jnen/nlw103.

Systematic review of severity scales and screening instruments for tics: Critique and recommendations

Martino D, Pringsheim TM, Cavanna AE, Colosimo C, Hartmann A, Leckman JF, Luo S, Munchau A, Goetz CG, Stebbins GT, Martinez-Martin P; Members of the MDS Committee on Rating Scales Development.

Mov Disord. 2017 Mar;32(3):467-473. doi: 10.1002/mds.26891. Epub 2017 Jan 10.

Nonmotor Symptoms in Parkinson Disease: A Descriptive Review on Social Cognition Ability

Palmeri R, Lo Buono V, Corallo F, Foti M, Di Lorenzo G, Bramanti P, Marino S.

J Geriatr Psychiatry Neurol. 2017 Mar;30(2):109-121. doi: 10.1177/0891988716687872. Epub 2017 Jan 11.

Misperceptions and Parkinson's disease

Friedman JH.

J Neurol Sci. 2017 Mar 15;374:42-46. doi: 10.1016/j.jns.2016.12.059. Epub 2017 Jan 4.

Cognitive-behavioural therapy for non-motor symptoms of Parkinson's disease: a clinical review

Koychev I, Okai D.

Evid Based Ment Health. 2017 Feb;20(1):15-20. doi: 10.1136/eb-2016-102574. Epub 2017 Jan 10.

Health benefits of methylxanthines in neurodegenerative diseases

Oñatibia-Astibia A, Franco R, Martínez-Pinilla E.

Mol Nutr Food Res. 2017 Jun;61(6). doi: 10.1002/mnfr.201600670. Epub 2017 Feb 22.

The c-Abl inhibitor in Parkinson disease

Zhou ZH, Wu YF, Wang XM, Han YZ.

Neurol Sci. 2017 Apr;38(4):547-552. doi: 10.1007/s10072-016-2808-2. Epub 2017 Jan 11.

Abnormalities of regional brain function in Parkinson's disease: a meta-analysis of resting state functional magnetic resonance imaging studies

Pan P, Zhang Y, Liu Y, Zhang H, Guan D, Xu Y.

Sci Rep. 2017 Jan 12;7:40469. doi: 10.1038/srep40469.

Long-Latency Somatosensory Evoked Potentials of the Subthalamic Nucleus in Patients with Parkinson's Disease

Trenado C, Elben S, Friggemann L, Gruhn S, Groiss SJ, Vesper J, Schnitzler A, Wojtecki L.

PLoS One. 2017 Jan 12;12(1):e0168151. doi: 10.1371/journal.pone.0168151. eCollection 2017.

Ferroptosis and cell death mechanisms in Parkinson's disease

Guiney SJ, Adlard PA, Bush AI, Finkelstein DI, Ayton S.

Neurochem Int. 2017 Mar;104:34-48. doi: 10.1016/j.neuint.2017.01.004. Epub 2017 Jan 9.

Understanding Parkinson's Disease through the Use of Cell Reprogramming

Playne R, Connor B.

Stem Cell Rev Rep. 2017 Apr;13(2):151-169. doi: 10.1007/s12015-017-9717-5.

Movement disorders in 2016: Progress in Parkinson disease and other movement disorders

Jankovic J.

Nat Rev Neurol. 2017 Feb;13(2):76-78. doi: 10.1038/nrneurol.2016.204. Epub 2017 Jan 13.

Wolff-Parkinson-White syndrome: lessons learnt and lessons remaining

Benson DW, Cohen MI.

Cardiol Young. 2017 Jan;27(S1):S62-S67. doi: 10.1017/S1047951116002250.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias